<b>Acute Myeloid Leukaemia – Newer Drugs in the pipelines</b> :   <b>Acute Myeloid Leukaemia – Newer Drugs in the pipelines</b>

The treatment of AML is categorized into two: remission induction therapy and post remission. A number of strategies have been utilized based on these categories; including conventional therapy, target therapy, etc. In this brief communication, a review of current drugs used in AML therapy is discussed. In addition, drugs in the pipeline are also discussed.

Content

Author and article information

Journal

Title: Annals of Tropical Medicine & Public Health

Publisher: Africa Health Research Organization

Publication date (Print): 1 June 2022

Volume: 1

Issue: 1

Affiliations

[1 ] Calcutta School of Tropical Medicine, Kolkata, India

Author notes

[* ]Email: propkb5@ 123456gmail.com .

Author information

Pranab Kumar Bhattacharya https://orcid.org/0000-0001-5430-3814

Article

DOI: 10.36295/ATMPH/2022/00010

SO-VID: 3e48e1c4-2e89-467c-be73-1582d59dd358

License:

This work has been published open access under Creative Commons Attribution License CC BY 4.0 , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Conditions, terms of use and publishing policy can be found at www.scienceopen.com .

History

Date received : 1 June 2022

Date accepted : 11 June 2022

Funding

Nil Nil

Data availability: All data generated or analysed during this study are included in this published article (and its supplementary information files).

ScienceOpen disciplines: Oncology & Radiotherapy,Pathology,Pharmacology & Pharmaceutical medicine

Keywords: Neutrophils,Remission,AML,Leukaemia,Therapy

References

Kadia T.M., Ravandi F., Cortes J., Kantarjian H.. New drugs in acute myeloid leukemia. Annals of Oncology. Vol. 27(5):770–778. 2016. Elsevier BV. [Cross Ref]
Stanchina Michele, Soong Deborah, Zheng-Lin Binbin, Watts Justin M., Taylor Justin. Advances in Acute Myeloid Leukemia: Recently Approved Therapies and Drugs in Development. Cancers. Vol. 12(11)2020. MDPI AG. [Cross Ref]
Stein Eytan M., Tallman Martin S.. Emerging therapeutic drugs for AML. Blood. Vol. 127(1):71–78. 2016. American Society of Hematology. [Cross Ref]
Yeoh Zhi Han, Bajel Ashish, Wei Andrew H.. New Drugs Bringing New Challenges to AML: A Brief Review. Journal of Personalized Medicine. Vol. 11(10)2021. MDPI AG. [Cross Ref]

Comments

Comment on this article

[1] Kadia T.M., Ravandi F., Cortes J., Kantarjian H.. New drugs in acute myeloid leukemia. Annals of Oncology. Vol. 27(5):770–778. 2016. Elsevier BV. [Cross Ref]

[2] Stanchina Michele, Soong Deborah, Zheng-Lin Binbin, Watts Justin M., Taylor Justin. Advances in Acute Myeloid Leukemia: Recently Approved Therapies and Drugs in Development. Cancers. Vol. 12(11)2020. MDPI AG. [Cross Ref]

[3] Stein Eytan M., Tallman Martin S.. Emerging therapeutic drugs for AML. Blood. Vol. 127(1):71–78. 2016. American Society of Hematology. [Cross Ref]

[4] Yeoh Zhi Han, Bajel Ashish, Wei Andrew H.. New Drugs Bringing New Challenges to AML: A Brief Review. Journal of Personalized Medicine. Vol. 11(10)2021. MDPI AG. [Cross Ref]